RETRACTION: ENKUR Recruits FBXW7 to Ubiquitinate and Degrade MYH9 and Further Suppress MYH9-Induced Deubiquitination of β-Catenin to Block Gastric Cancer Metastasis

doi:10.1002/mco2.70160

MedComm ›› 2025, Vol. 6 ›› Issue (3) : e70160 DOI: 10.1002/mco2.70160

RETRACTION

RETRACTION: ENKUR Recruits FBXW7 to Ubiquitinate and Degrade MYH9 and Further Suppress MYH9-Induced Deubiquitination of β-Catenin to Block Gastric Cancer Metastasis

Author information +

History +

PDF

Cite this article

Download citation ▾

null. RETRACTION: ENKUR Recruits FBXW7 to Ubiquitinate and Degrade MYH9 and Further Suppress MYH9-Induced Deubiquitination of β-Catenin to Block Gastric Cancer Metastasis. MedComm, 2025, 6(3): e70160 DOI:10.1002/mco2.70160

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	F. Ye, C. Chen, J. Qin, J. Liu, and C. Zheng, “Genetic Profiling Reveals an Alarming Rate of Cross-Contamination among Human Cell Lines Used in China,” The FASEB Journal 29 (2015): 4268–4272,

[2]	X. Bian, Z. Yang, H. Feng, H. Sun, and Y. Liu, “A Combination of Species Identification and STR Profiling Identifies Cross-Contaminated Cells From 482 Human Tumor Cell Lines,” Scientific Reports 7 (2017): 9774,

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.